ASCO GI: Bone Drugs Cut CRC Risk

SAN FRANCISCO (MedPage Today) — Postmenopausal women taking oral bisphosphonates for osteoporosis had almost a 50% reduction in the risk of colorectal cancer, according to a large cohort study.

Post a Comment

Comments are closed.